N-Ethylacetoacetamide
- CAS NO.:10138-46-2
- Empirical Formula: C6H11NO2
- Molecular Weight: 129.16
- SAFETY DATA SHEET (SDS)
- Update Date: 2023-07-14 17:43:59
What is N-Ethylacetoacetamide?
The Uses of N-Ethylacetoacetamide
N-Ethyl-3-oxobutanamide is a reagent used in the preparation of selective A3 Adenosine receptor antagonists.
Properties of N-Ethylacetoacetamide
| Boiling point: | 282.1±23.0 °C(Predicted) |
| Density | 0.988±0.06 g/cm3(Predicted) |
| pka | 11.98±0.46(Predicted) |
Safety information for N-Ethylacetoacetamide
Computed Descriptors for N-Ethylacetoacetamide
New Products
Cis-Tosylate Dibenzoyl-L-tartaric acid Anhydrous (Resolution Reagent) 1,2,3,9-Tetrahydro-9-Methyl-4H-Carbazole-4-One Dibenzo[b,f][1,4]thiazepin-11(10H)-one N-BOC-piperidine-4-carboxylic acid 1-Benzhydrylazetane-3-carbonitrile AMINO-(3-CHLORO-PHENYL)-ACETIC ACID 2-(2-Chlorophenyl)glycine (±)-amino(2-fluorophenyl)acetic acid 8-oxa-1,3-diazaspiro[4.5]decane-2,4-dione MEHYL AMINE-D3.HCL METHANE SULFONIC ACID-D4 PHOSPORIC ACID-D3 85 W% IN D2O DEUTERIUM OXIDE FOR NMR BENZENE-D6 TOLUENE-D3 5-Acetylsalicylamide 1-(3-Chlorophenyl)piperazine hydrochlorideRelated products of tetrahydrofuran
![N-[2-(1H-indol-3-yl)ethyl]-3-oxobutanamide](https://img.chemicalbook.in/CAS/20200401/GIF/CB71839422.gif)







You may like
-
N-Ethyl-3-oxobutanamide 10138-46-2 98%View Details
10138-46-2 -
7292-71-9 AMINO-(3-CHLORO-PHENYL)-ACETIC ACID 98+View Details
7292-71-9 -
84145-28-8 98+View Details
84145-28-8 -
2-(2-Chlorophenyl)glycine 98+View Details
88744-36-9 -
7292-71-9 AMINO-(3-CHLORO-PHENYL)-ACETIC ACID 98+View Details
7292-71-9 -
84145-28-8 98+View Details
84145-28-8 -
2-(2-Chlorophenyl)glycine 98+View Details
88744-36-9 -
8-oxa-1,3-diazaspiro[4.5]decane-2,4-dione 39124-19-1 98+View Details
39124-19-1
Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.
